It's close on 2 1/2 years since this was announced and us USians find ourselves left with a choice of Medtronic CGMs (which are effectively tied to Medtronic pumps) or Dexcom CGMs.
That's not a lot of choice.
At the time Abbott blamed "supply" problems (see the previous 2011 posts) but it is inconceivable that supply, or manufacturing, problems will hold a product back in one of the worlds major markets when that same product continues to be manufactured and supplied in the other major markets.
Elsewhere (http://integrateddiabetes.com/Articles/cgm/cgm%20comparisons%20for%... [diatribe]) "cost/reimbursement" problems were blamed. But this year the whole cost/reimbursement scene in the US changed with the introduction of many more insurance companies to the diabetic market. (I.e. insurance companies that, prior to Jan 1 2014, simply didn't cover diabetics.)
And in other places it is suggested that there were licensing issues with the original developer of the sensor Abbott was using.
Meanwhile it is clear that Abbott continues to market the FreeStyle Navigator II everywhere but the US and that the price is comparable with the Dexcom G4.
Does anyone have any idea about what is going on?
Abbott UK has this to say:
"Unfortunately FreeStyle Navigator II is not available in USA at the moment. If you would like to know if and eventually when it will be introduced in USA please contact our helpline in USA on (888) 522-5226."
Unfortunately the US number doesn't work - there's no way for me to avoid getting told about some major recall and then having the phone hung up (their voice response system is American speakers only!)